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ABSTRACT 
Helicobacter pylori is one of the most common infectious bacteria in the world that causes 
gastric diseases leading to cancer. The increase of multiple antibiotic resistance rates of H. pylori 
have been reported worldwide. Thus, development of novel drugs is urgently required. Piper 
betle has many therapeutic values in traditional medicine. In this study, therefore, we investigated 
antibacterial activity of P. betle extracts and their fractions against a H. pylori strain isolated in 
Vietnam. The agar disk diffusion assay showed inhibition zone of ethyl acetate extract and 
methanol extract from P. betle leaf that of were 46 mm and 32 mm in diameter, respectively. 
After fractionation of the ethyl acetate extract through silica gel column chromatography, two 
peaks, PD2 and PD3, out of 12 fractions showed the strongest antibacterial activity. PD2 was 
sub-fractionated further by re-chromatography on the silica gel column, and subfraction TK12 
gave best resolution on LC-MS analysis. Finally, 4 potential compounds, quercetrin, calodenin B, 
vitexin and plicatipyrone, were identified in TK12 fraction. 
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INTRODUCTION 
H. pylori is one of the most popular 
pathogens worldwide. According to the 
United States Center for Disease Control, 
approximately a half of the world’s population 
is infected with H. pylori. Recent research 
showed that H. pylori infection rate is still 
high in most countries with variances among 
geographical regions and different age groups 
(Frenck et al., 2003). The prevalence of H. 
pylori infection in developing countries such 
as South America, Eastern Europe, and Asia 
is higher than in developed countries such as 
North Europe and North America. In some 
coutries in Africa, more than 90% of adults 
are identified positive for H. pylori (Eusebi et 
al., 2014). According to the statistics, in 
Vietnam, roughly 60–70% of the population 
(about 56 millions) were infected with this 
bacterium (Fock & Ang, 2010). Helicobacter 
pylori infection has been treated with 
combination of several antibiotics such as 
amoxicillin, tetracycline, clarithromycin and 
metronidazole. However, according to the 
statistics, the antibiotic resistance of H. 
pylori is increasing with presence of more 
multidrug-resistant strains (Binh et al., 
2013). Thus, development of new drugs is an 
urgent demand. 
It should be noted that Vietnam has a rich 
medicinal resource background for the 
screening of natural compounds possessing 
antibacterial ability against H. pylori. Among 
those medicinal plants, Piper betle L in the 
Piperaceae family has many therapeutic 
values including wound healing and 
antioxidant properties. P. betle leaf has been 
used for the treatment of various diseases like 
bad breath, boils and abscesses, conjunctivitis, 
constipation, headache, itches, mastitis, 
mastoiditis, leucorrhoea, otorrhoea, swelling 
of gum, rheumatism, cuts and injuries. The 
leaf has significant antimicrobial and 
antifungal activities against many pathogens 
(Ali et al., 2010; Agarwal et al., 2012). The 
Indian traditional medicine identified P. betle 
leaves has digestive and pancreatic lipase 
stimulant activities (Prabhu et al., 1995). 
Besides, P. betle leaf can inhibit progression 
of gastric ulceration, helping in the faster 
healing (Arawwawala et al., 2014). Thus, in 
this study, we aimed to examine antibacterial 
activity against H. pylori and identify 
potential compounds to develop anti-H. pylori 
drugs from the P. betle leaf. 
MATERIALS AND METHODS 
Preparation of P. betle leave extracts 
Piper betle leaves were collected, then 
dried at 40
 o
C and stored at 4
o
C. The leaves 
were extracted in ethyl acetate and methanol 
solvents following the procedure described in 
a previous study (Pham et al., 2017). Firstly, 
the powdered leaf part (5 g) was homogenized 
in 100 mL ethyl acetate using a mortar and 
pestle, followed by sonication for 5 min and 
stirring for 60 min at room temperature. The 
homogenate was centrifuged at 5,000 × g for 
10 min at 10°C and the supernatant was 
collected by filtration. The residue was 
extracted once again with 100 mL ethyl 
acetate and all supernatants were combined to 
obtain the ethyl acetate extract. Then the dried 
residue was successively extracted twice with 
100 mL methanol with the same procedure to 
get a methanol extract. The organic solvents 
were removed by vacuum rotary evaporation. 
The dried extracts were weighed and stored at 
-20
o
C until use. 
Isolation of Helicobacter pylori strains and 
cultivation 
Biopsies were stained with Giemsa 
agents to specify the presence of H. pylori 
bacteria. Positive samples were crushed by 
pestle blades and implanted in 5% sheep 
blood and selective antibiotics for 
Helicobacter pylori selective supply. Agar 
plates were incubated at 37
o
C under an 
aerobic condition created by the GasPakTM 
environmental bag (Becton, Dickinson 
and Company,  USA). Results were read 
after 7 days with the appearance of small, 
transparent colonies with diameter of 1– 
2 mm. Tests used to identify H. pylori 
bacteria including Gram staining, the ability 
to produce urease, catalase, oxidase, and 
PCR with H. pylori -specific lipase primers. 
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Column chromatography 
In the first step, 25 g of silica gel was 
saturated in the first solvent system (50% n-
hexane: 50% ethyl acetate) and was packed 
into a column. The ethyl acetate extract (200 
mg) was applied on the top of silica gel. The 
components of extract were continuously 
eluted by six solvent systems with increasing 
polarity including 50% n-hexane: 50% ethyl 
acetate, 30% n-hexane: 70% ethyl acetate, 
90% ethyl acetate: 10% methanol, 60% ethyl 
acetate: 40% methanol, 30% ethyl acetate: 
70% methanol, and 100% methanol. The 
eluents were collected in tubes (3 ml/ tube) 
as a serial 12 fractions designted from PD1 
to PD12. 
In the second step, the PD2 fraction was 
further fractionated by subsequent silicagel 
column chromatography. An amount of 85 
mg of PD2 fraction was loaded for onto the 
column and continuously eluted by six other 
solvent systems including 100% n-hexane, 
70% n-hexane: 30% ethyl acetate, 50% n-
hexane: 50% ethyl acetate, 30% n-hexane: 
70% ethyl acetate, 100% ethyl acetate, and 
50% ethyl acetate: 50% methanol. The 
eluents were collected in tubes (3 ml/ tube) 
as a serial 12 sub-fractions designated from 
TK1 to TK12. 
TLC chromatogram of 12 sub-fractions 
In this experiment, silica gel 60 F254 TLC 
Sheets (6.5 cm × 10 cm) were used as a 
stationary phase. An amount of 0.5 mg of 
each sub-fraction (TK1-TK12) was loaded on 
TLC. The TLC was then devoloped in solvent 
systems of 60% n- hexane: 40% ethyl acetate 
as mobile phase. Patterns on the TLC 
chromatogram were detected at 254 nm, 356 
nm UV light (UVP Lamp, Cambridge, UK). 
Liquid chromatography-mass spectrometry 
(LC-MS) 
High performance liquid chromatography 
(HPLC) coupled with mass spectrum was 
used to identify potential compounds in the 
active fraction. An amount of 3 µl samples 
was injected into C18 - RP column (4.6 ×  
250 mm, Phenomenex, USA) and separated in 
a gradient of 78–92% MeOH in deionized 
water for 37 min. The measurements were 
carried out at the Institute of Pharmaceutical 
Biology, University of Greifswald, Germany. 
Determination of antibacterial activity 
Agar diffusion method was performed as 
per Mitscher et al. (1972) with slight 
modifications (Mitscher et al., 1972). The 
dried extract was dissolved in DMSO to 
obtain a solution of 200 mg/ml. Prior to the 
test, 20 μl of extract (200 mg/ml) was added 
to the paper disc and air-dried for 3 hr. 
Helicobactor pylori was mixed into a 
suspension of the McFarland turbidity of 2 
(OD625nm = 0.451, approximately 6×10
8
 
CFU/ml) and streaked on a surface of blood 
agar plate. After that, the paper disc was 
placed on the surface of bacteria and 
incubated under a microaerophilic condition 
at 37
o
C. Antibacterial zones were measured 5 
days later. 
RESULTS AND DISCUSSION 
Antibacterial activity of the extracts 
The ethyl acetate extract from Piper betel 
leaves has 1.5 times stronger anti-bacterial 
activity against H. pylori compared to the 
methanol extract (46 vs. 32 mm inhibition 
zone diameter, respectively). This result is 
comparable with the previous publication of 
the inhibitory effect of P. betle leaf extract 
against H. pylori (Nguyen Van Toai, 2003). 
Therefore, the ethyl acetate extract of 
the P. betle leaf was selected for further 
isolation of active compounds using 
chromatography method. 
Antibacterial activity of silica-gel column 
chromatography fractions 
After silica-gel column chrpmatograpy of 
the ethyl acetate extract, 9/12 fractions  had 
antibacterial activity against H. pylori with 
diameter ≥ 10 mm (figure 1). 
In detail, 12 fractions can be divided into 
4 groups based on H. pylori inhibitory activity 
by the diameter of inhibition zone (IZD): no 
activity (PD1); the weak group with IZD < 10 
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mm (PD6 and 7 fraction); moderate group 
with IZD range of 10–30 mm (PD 4, 5, 8–12); 
the strong group with IZD fluctuating > 30 
mm (PD2, 3). Apparently the antibacterial 
activity against H. pylori is localized mainly 
in fraction PD2 followed by PD3. Thus, PD2 
fraction was analyzed further to find 
antibacterial compounds against H. pylori. 
 
  
Figure 1. Antibacterial activity of 12 fractions against H. pylori 
 
Identification of potential antibacterial 
compound in Piper betle leaf 
Sub-fractionation of PD2 fraction 
Before LC-MS analysis, PD2 fraction 
was fractionated further into sub-fractions by 
silica gel column chromatography. From  
85 mg of PD2 fraction, 12 sub-fractions 
(TK1-TK12) were collected after elution 
with 6 solvent systems. TLC analysis  
(figure 2) revealed that 12 sub-fractions were 
different from each other with distinct TLC 
patterns. All of these sub-fractions were 
analysed using LC-MS. 
 
 
Figure 2. TLC chromatogram of 12 fractions at 254 nm 
 
Identification the potential compounds in 
TK12 fraction 
All of 12 sub-fractions (TK1-TK12) were 
analyzed by analytical HPLC with detection at 
190 nm in 37 min. The chromatograms of 12 
sub-fractions were overlayed and shown in 
Figure 3a. Among 12 fractions, TK12 fraction 
gave the best spectrophotometric signal of its 
components. There were 8 peaks eluated at 
the corresponding time of minute 2, 5, 12.5, 
13.2, 15.5, 18.5, 20.5 and 23 (Figure 3a), 
which were analyzed on MS. MS of TK12 
fraction at 13.2 min indicated the occurrence 
of 5 pairs of compounds with 16 Da intervals 
in molecular mass. 
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(a) (b) 
Figure 3. (a) Overlay HPLC chromatograms of 12 sub-fractions (TK1-TK12), (b) Mass 
spectrum of compounds appeared at 13.2 min in negative mode. Molecular weight of  
each peak is given as a blue fonts 
 
We determined two potential compound 
groups including Group 1 with molecular 
weight ranging from 274.5–306.4 Da and 
Group 2 from 418.3–450.2 Da. The 
compounds in each group were divided into 
pairs with 16 Da apart such as Group 1 
including 2 pairs: 274.5–290.4 and 290.4–
306.4, Group 2 including 3 pairs: 418.3–
434.3, 432.3–448.3 and 434.3–450.2. The 
investigation of compounds based on the 
library of natural products identified 4 
compounds as shown in figure 4. 
 
 
Figure 4. Prediction of potential compounds 
 
These compounds, including quercetrin, 
MW of 448; calodenin, MW of 524; vitexin, 
MW of 434; plicatipyrone, MW of 418, were 
previously extracted from other plants with 
strong antibacterial activity, and also included 
in the list of compounds from P. betle leaf 
(Pradhan et al., 2013; Snow et al., 2016; 
Ghosh et al., 2014; Tang et al., 2003). Yet, 
none of those compounds has investigated 
their anti-H. pylori activity. 
CONCLUSION 
Ethyl acetate extract of P. betle leaf 
sample had strong anti-H. pylori activity with 
diameter of inhibition zone of 46 mm. Two 
consecutive fractionations of this extract using 
silica gel column chromatography yielded 12 
fractions and the anti-H. pylori activity was 
concentrated in PD2 fraction. By the second 
run of the column chromatography, 12 sub-
fractions (TK1-TK12) from PD2 fraction with 
the first column. Among sub-fractions, TK12 
gave the best resolution in the component 
analysis by LC-MS, in which 4 potential 
compounds have been predicted to be 
quercetrin, calodenin B, vitexin and 
plicatipyrone. 
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